IL15 and cancer: The cancer immunotherapy field currently focuses on combining the use of IL-15 with other agents, i.e., checkpoint inhibitors, monoclonal antibodies, chemotherapy, radiation, and chimeric antigen receptor T (CAR-T) cells, in order to target multiple mechanisms and enhance the immune response against tumors.